Dupilumab Promising for Children Aged 1-11 With EoE Dupilumab Promising for Children Aged 1-11 With EoE

New evidence supports the safety and efficacy of dupilumab for children aged 1-11 years with eosinophilic esophagitis.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news